PLG and neoplasm: The first candidate could be the Urokinase-type Plasminogen Activator (uPA), a serin protease involved in the activation of plasminogen to plasmin and in the degradation of the extracellular matrix, thus favoring tumor cell migration from the primary to a secondary site.